SCHEMBL6797107

SCHEMBL6797107

CCC(=O)OC1=C(C)CCCC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.35
ELANE P08246 1/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ESR1 P03372 1/20 0.33
RECQL P46063 1/20 0.33
HIF1A Q16665 1/20 0.33
MEN1 O00255 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ACHE P22303 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18339252 0.89 ELANE (0.35) ELANEKMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL18339154 0.75 ALDH1A1 (0.39) BRD4KMT2AKDM4EALDH1A1LMNA
SCHEMBL28243472 0.73 BRD4 (0.37) BRD4KMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL4954564 0.70 GAA (0.35) ELANEKMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL10861612 0.67 CYP19A1 (0.36) ELANEKDM4EHSD17B10ALDH1A1LMNA
SCHEMBL29110658 0.66 BRD4 (0.49) BRD4KMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL23706744 0.65 HIF1A (0.38) ELANEKMT2AALDH1A1GAAHPGD
SCHEMBL28405509 0.64 KDM4E (0.39) ELANEKMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL7387791 0.63 ESR1 (0.34) ELANEKMT2ASMN1; SMN2ESR1RECQL
SCHEMBL9383521 0.62 MAOA (0.51) BRD4MAPTGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040224926-A1 Inhibitory or blocking agents of molecular generating and/or inducing functions KOYAMA SHOZO (JP) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224926-A1 Inhibitory or blocking agents of molecular generating and/or inducing functions CD47, MCL1, CD74 BRD4 2551/4885ELANE 377/4885KMT2A 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.